Cite
MLA Citation
Indranil Bhattacharya et al.. “Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Domagrozumab (PF‐06252616), an Antimyostatin Monoclonal Antibody, in Healthy Subjects.” Clinical pharmacology in drug development, vol. 7, no. 5, 2018, pp. 484–497. http://access.bl.uk/ark:/81055/vdc_100066419680.0x00000d